Chaga mushroom market seen reaching $1.4 billion by 2031

Allied Market Research says the global chaga mushroom market was valued at $1.4 billion and is projected to grow at a 7.2% CAGR from 2022 to 2031. The outlook is tied to rising demand for functional foods, dietary supplements, cosmetics and natural health products across North America, Europe, Asia-Pacific and LAMEA.

Why it matters: - Chaga is moving from a niche ingredient into a broader functional mushroom category with real demand across food, supplements, cosmetics and pharmaceuticals. - The market’s growth could reshape sourcing, processing and product development for brands selling natural health and wellness products. - The report also flags supply constraints, climate sensitivity and limited birch-tree availability as factors that could restrict wild chaga output.

What happened: - Allied Market Research published a forecast report on the global chaga mushroom market covering 2021 to 2031. - The report values the market at $1.4 billion and projects a 7.2% CAGR during 2022-2031. - The analysis covers market size, share, competitive landscape, trends, value chain dynamics and regional performance. - The study also includes strategic frameworks, regulatory themes and technology trends expected across the forecast period. - The report includes a sample request link: Request a sample copy.

The details: - Consumer demand for functional mushrooms, natural remedies and organic dietary supplements is a key growth driver. - Chaga is used in food and beverages, cosmetics and beauty care products, pharmaceuticals and nutraceuticals. - The report cites chaga’s bioactive profile, including anticancer, anti-inflammatory, antiviral, antioxidant, hypoglycemic and hypolipidemic properties. - Chaga also contains zinc, copper, magnesium, selenium, potassium and vitamins B, C and E. - Wild chaga harvesting, organic and conventional processing, and powder and liquid extraction are part of the market ecosystem. - The report says organic chaga held about 45.4% of global market share in 2021. - Powder was the dominant form in 2021 at $475.6 million and is projected to reach $910.2 million by 2031 at a 6.9% CAGR. - Liquid is the other main product form. - Food and beverage is a major growth segment because of chaga extracts used as flavoring and nutritional ingredients. - Cosmetics and personal care is growing as companies launch products with chaga as a key component. - Pharmaceuticals are projected to reach $228.6 million by 2031 at a 7.8% CAGR. - Dietary supplements remain a major end-use category. - Europe was the largest regional market in 2021. - North America is growing rapidly. - Asia-Pacific is expanding with rising functional food awareness and a growing nutraceutical industry. - LAMEA is emerging as supplement and natural product demand builds. - The report names these companies among the players analyzed: Baikal Herbs Ltd., Fungi Perfecti LLC, Annanda Chaga Mushrooms, Bioway (Xi'an) Organic Ingredients Co. Ltd., Sayan Health, Inc., Eartherbs L.L.C., Aloha Medicinals, Oregon Mushrooms Co., Mahogany Organics Private Limited, The Chaga Company LLC., NutraCap Labs, L.L.C., Canadian Pine Pollen Company, The Brainfood Mushroom Company, Touchwood Mushrooms, FreshCap Mushrooms Ltd. and Om Mushroom Superfood. - The report includes buy now with discount and purchase enquiry links.

Between the lines: - The report frames chaga as part of a larger shift toward plant-based wellness and ingredient traceability. - Interest in biotechnology, automated sterilization and artificial production media points to a push to reduce dependence on wild harvesting. - Organic certification and ESG-linked harvesting practices appear increasingly important for market access and pricing. - The competitive field is still fragmented, which gives suppliers and brands room to compete on sourcing, processing and product claims.

What's next: - Market growth is likely to depend on how well the industry scales cultivation and extraction while managing supply limits. - New product launches, acquisitions and portfolio expansion could shape market share over the next several years. - Regulatory standards, climate conditions and forest access will remain key variables for producers and investors. - Allied Market Research’s report also points to ongoing demand for segment-level and regional forecasts through 2031.

The bottom line: - Chaga is becoming a mainstream functional ingredient market, but long-term growth will depend on supply stability and efficient processing.